Evidence map›Paper›PMID 37098897›Full record

ArticleMicrobiology spectrum2023

New Perspectives on Escherichia coli Signal Peptidase I Substrate Specificity: Investigating Why the TasA Cleavage Site Is Incompatible with LepB Cleavage.

Joanna E Musik, Jessica Poole, Christopher J Day, Thomas Haselhorst, Freda E-C Jen, Thomas Ve, Veronika Masic, Michael P Jennings, Yaramah M Zalucki

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Joanna E MusikInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Jessica PooleInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Christopher J DayInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Thomas HaselhorstInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Freda E-C JenInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Thomas VeInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Veronika MasicInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Michael P JenningsInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.ORCID 0000-0002-1027-4684
Yaramah M ZaluckiInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.ORCID 0000-0001-7947-8143
Griffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escherichia coli signal peptidase I (LepB) has been shown to inefficiently cleave secreted proteins with aromatic amino acids at the second position after the signal peptidase cleavage site (P2'). The Bacillus subtilis exported protein TasA contains a phenylalanine at P2', which in B. subtilis is cleaved by a dedicated archaeal-organism-like signal peptidase, SipW. We have previously shown that when the TasA signal peptide is fused to maltose binding protein (MBP) up to the P2' position, the TasA-MBP fusion protein is cleaved very inefficiently by LepB. However, the precise reason why the TasA signal peptide hinders cleavage by LepB is not known. In this study, a set of 11 peptides were designed to mimic the inefficiently cleaved secreted proteins, wild-type TasA and TasA-MBP fusions, to determine whether the peptides interact with and inhibit the function of LepB. The binding affinity and inhibitory potential of the peptides against LepB were assessed by surface plasmon resonance (SPR) and a LepB enzyme activity assay. Molecular modeling of the interaction between TasA signal peptide and LepB indicated that the tryptophan residue at P2 (two amino acids before the cleavage site) inhibited the active site serine-90 residue on LepB from accessing the cleavage site. Replacing the P2 tryptophan with alanine (W26A) allowed for more efficient processing of the signal peptide when the TasA-MBP fusion was expressed in E. coli. The importance of this residue to inhibit signal peptide cleavage and the potential to design LepB inhibitors based on the TasA signal peptide are discussed.

Indexed as

Escherichia coliEscherichia coli ProteinsAmino Acid SequenceHumansMembrane ProteinsProtein Sorting SignalsSerine EndopeptidasesSubstrate SpecificityTryptophanEscherichia coli ProteinsMembrane ProteinsProtein Sorting SignalsSerine EndopeptidasesTryptophantype I signal peptidaseLepBsecretionsignal peptidase Isubstrate specificityTasA

Identifiers

PMID37098897
PMCPMC10269814
OpenAlexW4367048105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.